首页> Human pathology> "Percentage" and "size" of residual viable tumor in lymph node, the performance in estimating pathologic response of lymph node in non-small cell lung cancer treated with neoadjuvant chemoimmunotherapy.

"Percentage" and "size" of residual viable tumor in lymph node, the performance in estimating pathologic response of lymph node in non-small cell lung cancer treated with neoadjuvant chemoimmunotherapy.

导出 LinkOut

翻译打印收藏纠错

第一作者： Wei,Sun

第一单位： Department of Pathology, Peking University Cancer Hospital & Institute, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Beijing, China.

作者： Wei,Sun ^[1] ; Linlin,Qu ^[2] ; Jianghua,Wu ^[1] ; Xinying,Liu ^[1] ; Chenglong,Wang ^[1] ; Yumeng,Jiang ^[1] ; Yuliang,Liu ^[3] ; Mailin,Chen ^[3] ; Xun,Wang ^[4] ; Dongmei,Lin ^[5]

作者单位： Department of Pathology, Peking University Cancer Hospital & Institute, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Beijing, China. ^[1] Department of Pathology, Peking University People's Hospital, Beijing, China. ^[2] Department of Radiology, Peking University Cancer Hospital & Institute, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Beijing, China. ^[3] Department of Thoracic Surgery, Peking University People's Hospital, Beijing, China; Thoracic Oncology Institute, Peking University People's Hospital, Beijing, China. ^[4] Department of Pathology, Peking University Cancer Hospital & Institute, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Beijing, China. Electronic address: lindm3@bjmu.edu.cn. ^[5]

关键词 Metastatic tumor size Neoadjuvant chemoimmunotherapy Non-small cell lung cancer Percentage of residual viable tumor